Operating profit before deduction of amortization: Pharvaris (PHVS)
Pharvaris N.V. (PHVS) maintains a resilient business driven by protected capital and cost control, as evidenced by its financial EBITDA. The 0.00 level represents the current value of this curve. The company develops innovative tablets for the therapy of hereditary angioedema, targeting the orphan drug segment. Lars Nibel's strategic direction ensures a high level of scientific readiness for the future market launch of the drug.
Pharvaris (PHVS) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
- earnings and multiples data:
PHVS - Company Net Income|Expected Net Income Pharvaris N.V.|PHVS - Price to Earnings Ratio|Future Price to Earnings pharvaris.com|PHVS - PEG Multiple|EV/EBITDA Multiple Pharvaris|PHVS - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Pharvaris|PHVS - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months pharvaris.com|PHVS - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Pharvaris N.V.
Analysis of all company metrics:Pharvaris Pharma, PHVS
The monetization of innovative tablets for the treatment of HAE forms the primary cash flow for Pharvaris N.V. (PHVS). This figure is calculated by excluding depreciation, taxes, and interest expenses from operating profit. The metric reflects the business's actual ability to generate cash, independent of accounting conventions. The trend in annual EBITDA serves as an indicator of the company's fundamental stability. Analysis of this chart allows for an assessment of the drug's commercialization efficiency regardless of the debt load.
Who Pharvaris N.V. competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BCRX - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization VERA|DNTH: Operating profit EBITDA|AbCellera - Income before deduction of interest, taxes and amortization|TRML (Tourmaline Bio) - Operating profit EBITDA|Operating profit EBITDA Precigen Inc|Profit before payment of interest, taxes and amortization Pharming (PHAR)|NKTR (Nektar Corp) - Income before deduction of interest, taxes and amortization|Upstream Bio Inc - Operating profit before deduction of amortization|zenasbio.com - Profit before payment of interest, taxes and amortization|Immunome - Operating profit EBITDA|GOSS - Operating profit EBITDA|KalVista Pharmaceuticals Inc (KALV) - Profit before payment of interest, taxes and amortization|Septerna Pharma - Income before deduction of interest, taxes and amortization|PVLA (Pieris Pharmaceuticals) - Operating profit EBITDA|savarapharma.com (SVRA) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Rigel Pharmaceuticals, Inc. (RIGL)|Operating income before deduction of amortization AnaptysBio Inc|Astria Pharma - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization ENGN|RAPT - Profit before payment of interest, taxes and amortization|JBIO (Aerovate Therapeutics Inc) - Operating profit before amortization|ACRS (Aclaris Therapeutics, Inc.) - Operating profit before deduction of amortization|KYTX - Operating income before deduction of amortization|Operating profit before deduction of amortization TLSA|Profit before payment of interest, taxes and amortization CABA|Operating profit before deduction of amortization VTYX (Ventyx Biosciences)|Operating income before deduction of amortization theratech.com|Profit before payment of interest, taxes and amortization Avalo Therapeutics AVTX|ELDN (Eledon Pharmaceuticals Inc.) - Profit before deduction of interest, taxes, depreciation and amortization|Agenus Inc - Operating profit EBITDA|Income before deduction of interest, taxes and amortization CLYM (Climb Bio, Inc)|ZURA (Zura Bio) - Operating profit before deduction of amortization|ATYR (atyrpharma.com) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Adagene Inc|Ikena Oncology, Inc. (IMA) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Shattuck Labs, Inc. (STTK)|EQ: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA CNTB (Connect Biopharma Holdings Limited)|Income before deduction of interest, taxes and amortization IMUX|Atara Biotherapeutics Inc - Operating profit EBITDA|IFRX - Operating profit EBITDA|X4 Pharma (XFOR) - Profit before payment of interest, taxes and amortization|Adicet Bio, Inc. - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Celularity Inc|Operating profit before deduction of amortization inmunebio.com (INMB)|Operating profit EBITDA BRNS|Operating profit EBITDA Kezar Life Sciences Inc. (KZR)|SAB Biotherapeutics, Inc - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AKTX|Enlivex Therapeutics, Ltd. - Operating profit EBITDA|Operating income before deduction of amortization Q32 Bio Inc. QTTB|GeoVax (GOVX) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Edesa Biotech Inc|Profit before payment of interest, taxes and amortization iBio Corp|Operating profit before deduction of amortization Carisma Tx (CARM)|Operating profit before deduction of amortization XTLB (XTL Biopharmaceuticals)|Operating profit EBITDA boltbio.com (BOLT)|Profit before payment of interest, taxes and amortization HCW Biologics HCWB|APVO: Operating profit before amortization|AIM ImmunoTech Inc. - Operating profit EBITDA|Profit before interest, taxes and amortization Aditxt|GRI Bio, Inc. (GRI) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization XRTX (xortx.com)|HIND (Vyome Holdings) - Operating profit EBITDA|REVB: Income before deduction of interest, taxes and amortization|Operating profit EBITDA INDP|Operating profit EBITDA BiondVax Pharmaceuticals (SCNI)|Profit before payment of interest, taxes and amortization CalciMedica CALI|Income before deduction of interest, taxes and amortization AFMD|ALLK: Operating profit before deduction of amortization|HOOK: Profit before payment of interest, taxes and amortization|IGMS: Operating profit EBITDA|iTeos Pharma (ITOS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Ocean Biomedical, Inc.|TCBP: Income before deduction of interest, taxes and amortization|Operating profit EBITDA THRD
